Helius Medical Technologies, Inc.
(Toronto Stock Exchange : HSDT)

( )
HSDT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.54%580.801.0%$817.23m
DHRDanaher Corp. -0.59%285.310.7%$631.56m
ISRGIntuitive Surgical, Inc. -2.61%232.880.8%$506.40m
ABTAbbott Laboratories -0.96%107.950.8%$472.87m
MDTMedtronic Plc -0.50%93.110.6%$415.10m
SYKStryker Corp. -1.09%214.951.3%$366.31m
BSXBoston Scientific Corp. 0.15%41.031.0%$306.78m
EWEdwards Lifesciences Corp. -3.82%101.440.4%$250.54m
ALGNAlign Technology, Inc. -6.63%273.646.4%$247.16m
DXCMDexCom, Inc. -6.87%85.121.9%$242.21m
BDXBecton, Dickinson & Co. -0.27%255.281.0%$221.09m
IDXXIDEXX Laboratories, Inc. -4.52%388.603.8%$216.95m
BAXBaxter International, Inc. -1.26%58.961.8%$189.90m
AAgilent Technologies, Inc. -2.75%128.871.7%$168.64m
MTDMettler-Toledo International, Inc. -1.99%1315.405.9%$150.23m

Company Profile

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.